GT Biopharma (GTBP) Inventory Average (2012 - 2014)
GT Biopharma's (GTBP) quarterly Inventory Average came in at $42000.0 in Q1 2014, down 45.1% year-over-year from $76500.0 in Q1 2013, and down 45.1% quarter-over-quarter from $76500.0 in Q1 2013.
Analysis
GT Biopharma (GTBP) Inventory Average (2012 - 2014) Analysis & Trends
GT Biopharma (GTBP) has reported Inventory Average for 3 consecutive years, with $42000.0 the latest figure, recorded in Q1 2014.
- On a quarterly basis, Inventory Average fell 45.1% year-over-year to $42000.0 in Q1 2014; TTM through Mar 2014 was $42000.0, a 45.1% decrease from a year earlier, with the FY2013 full-year figure at $50500.0, up 42.25% from the prior year.
- Inventory Average was $42000.0 for Q1 2014 at GT Biopharma, down from $76500.0 in the prior quarter.
- Over five years, Inventory Average peaked at $76500.0 in Q1 2013 and troughed at $12000.0 in Q1 2012.
- A 3-year average of $45625.0 and a median of $47000.0 in 2012 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average surged 537.5% in 2013 and sank 45.1% in 2014, its largest moves.
- Over 3 years, Inventory Average stood at $52000.0 in 2012, then soared by 47.12% to $76500.0 in 2013, then plunged by 45.1% to $42000.0 in 2014.
- The last three Inventory Average figures came in at $42000.0 (Q1 2014), $76500.0 (Q1 2013), and $52000.0 (Q2 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 137.65 Mn |
| 10 | GT Biopharma | 337,746.23 | 337,746.23 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2014 | 42,000.00 |
| Mar 31, 2013 | 76,500.00 |
| Jun 30, 2012 | 52,000.00 |
| Mar 31, 2012 | 12,000.00 |